187 related articles for article (PubMed ID: 17681004)
41. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux.
Miller S
Curr Med Res Opin; 1999; 15(3):160-8. PubMed ID: 10621922
[TBL] [Abstract][Full Text] [Related]
42. [Influence of sodium alginate on the intestinal transit in low birth weight newborn infants].
Chouraqui JP; Morer I; Renard P; Bielsky MC; Richard-Berthe C; Rambaud P
Pediatrie; 1993; 48(6):473-7. PubMed ID: 8247649
[TBL] [Abstract][Full Text] [Related]
43. Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.
Yuan YZ; Fang JY; Zou DW; Levinson N; Jenner B; Wilkinson J
J Dig Dis; 2016 Nov; 17(11):725-734. PubMed ID: 27622897
[TBL] [Abstract][Full Text] [Related]
44. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children.
Forbes D; Hodgson M; Hill R
J Pediatr Gastroenterol Nutr; 1986; 5(4):556-9. PubMed ID: 3016226
[TBL] [Abstract][Full Text] [Related]
45. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.
Greally P; Hampton FJ; MacFadyen UM; Simpson H
Arch Dis Child; 1992 May; 67(5):618-21. PubMed ID: 1599300
[TBL] [Abstract][Full Text] [Related]
46. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.
Kwiatek MA; Roman S; Fareeduddin A; Pandolfino JE; Kahrilas PJ
Aliment Pharmacol Ther; 2011 Jul; 34(1):59-66. PubMed ID: 21535446
[TBL] [Abstract][Full Text] [Related]
47. [A successful treatment of gastro-oesophageal reflux in infancy with Gaviscon].
Gross-Kieselstein E; Branski D; Abrahamov A
Harefuah; 1975 Oct; 89(7):327-9. PubMed ID: 171200
[No Abstract] [Full Text] [Related]
48. [Gastroesophageal reflux disease during pregnancy].
Elokhina TB; Tiutiunnik VL
Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
[No Abstract] [Full Text] [Related]
49. Ranitidine, cimetidine, antacids, and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study.
Desechalliers JP; Galmiche JP; Touchais JY; Denis P; Colin R
Int J Clin Pharmacol Res; 1984; 4(3):217-22. PubMed ID: 6092288
[TBL] [Abstract][Full Text] [Related]
50. A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux.
Barnardo DE; Lancaster-Smith M; Strickland ID; Wright JT
Curr Med Res Opin; 1975; 3(6):388-91. PubMed ID: 1183220
[TBL] [Abstract][Full Text] [Related]
51. [Multicenter study of sodium alginate in the treatment of regurgitation in infants].
Le Luyer B; Mougenot JF; Mashako L; Chapoy P; Olives JP; Morali A; Chevallier B; Ginies JL; Dupont C; Dagorne M
Ann Pediatr (Paris); 1992 Dec; 39(10):635-40. PubMed ID: 1485782
[TBL] [Abstract][Full Text] [Related]
52. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
[TBL] [Abstract][Full Text] [Related]
53. Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid.
Castell DO; Dalton CB; Becker D; Sinclair J; Castell JA
Dig Dis Sci; 1992 Apr; 37(4):589-93. PubMed ID: 1551350
[TBL] [Abstract][Full Text] [Related]
54. [Esophageal reflux and peptic ulcer. An exclusive advanced education service of the Gastro-Liga for family physicians].
Fortschr Med; 1998 Dec; 116(34):35-8. PubMed ID: 10024760
[No Abstract] [Full Text] [Related]
55. [Therapeutic procedures in gastroesophageal reflux disease].
Tytgat GN
Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
[TBL] [Abstract][Full Text] [Related]
56. Managing childhood gastro-oesophageal reflux.
Drug Ther Bull; 1997 Oct; 35(10):77-80. PubMed ID: 9489057
[No Abstract] [Full Text] [Related]
57. A comparative crossover study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium--aluminium antacid gel.
Chevrel B
J Int Med Res; 1980; 8(4):300-2. PubMed ID: 6250928
[TBL] [Abstract][Full Text] [Related]
58. Rinsing with antacid suspension reduces hydrochloric acid-induced erosion.
Alves Mdo S; Mantilla TF; Bridi EC; Basting RT; França FM; Amaral FL; Turssi CP
Arch Oral Biol; 2016 Jan; 61():66-70. PubMed ID: 26519789
[TBL] [Abstract][Full Text] [Related]
59. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
Coyle C; Crawford G; Wilkinson J; Thomas SJ; Bytzer P
Aliment Pharmacol Ther; 2017 Jun; 45(12):1524-1533. PubMed ID: 28464343
[TBL] [Abstract][Full Text] [Related]
60. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.
Smart HL; Atkinson M
J R Soc Med; 1990 Sep; 83(9):554-6. PubMed ID: 2213800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
